ZA931799B - Semi-synthetic glycosaminoglycans containing alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3 - Google Patents
Semi-synthetic glycosaminoglycans containing alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3Info
- Publication number
- ZA931799B ZA931799B ZA931799A ZA931799A ZA931799B ZA 931799 B ZA931799 B ZA 931799B ZA 931799 A ZA931799 A ZA 931799A ZA 931799 A ZA931799 A ZA 931799A ZA 931799 B ZA931799 B ZA 931799B
- Authority
- ZA
- South Africa
- Prior art keywords
- semi
- synthetic glycosaminoglycans
- galacturonic acid
- acid substituted
- alpha
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 4
- 230000000269 nucleophilic effect Effects 0.000 title abstract 2
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 229920002971 Heparan sulfate Chemical group 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002429 anti-coagulating effect Effects 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITBO920140A IT1260136B (it) | 1992-04-17 | 1992-04-17 | Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA931799B true ZA931799B (en) | 1993-12-27 |
Family
ID=11338174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA931799A ZA931799B (en) | 1992-04-17 | 1993-03-12 | Semi-synthetic glycosaminoglycans containing alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5430132A (no) |
| EP (1) | EP0565862B1 (no) |
| JP (1) | JP2702377B2 (no) |
| KR (1) | KR0171623B1 (no) |
| AT (1) | ATE154615T1 (no) |
| AU (1) | AU658499B2 (no) |
| CA (1) | CA2093148C (no) |
| DE (1) | DE69311618T2 (no) |
| DK (1) | DK0565862T3 (no) |
| ES (1) | ES2103991T3 (no) |
| FI (1) | FI106555B (no) |
| GR (1) | GR3024582T3 (no) |
| IL (1) | IL105111A (no) |
| IT (1) | IT1260136B (no) |
| NO (1) | NO306305B1 (no) |
| NZ (1) | NZ247197A (no) |
| TW (1) | TW229213B (no) |
| ZA (1) | ZA931799B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1260137B (it) * | 1992-04-17 | 1996-03-28 | Alfa Wassermann Spa | Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato |
| US5696100A (en) * | 1992-12-22 | 1997-12-09 | Glycomed Incorporated | Method for controlling O-desulfation of heparin and compositions produced thereby |
| IT1264102B1 (it) * | 1993-03-29 | 1996-09-10 | Alfa Wassermann Spa | Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali |
| IT1264101B1 (it) * | 1993-03-29 | 1996-09-10 | Alfa Wassermann Spa | Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 |
| US6127347A (en) * | 1994-01-12 | 2000-10-03 | Univ Michigan | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| US5583121A (en) * | 1994-01-12 | 1996-12-10 | Michigan State University | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| NO984143L (no) | 1998-09-09 | 2000-03-10 | Norsk Hydro As | Ny prosess for å fremstille overflatemodifiserende stoffer |
| HUP0201712A3 (en) * | 1999-06-30 | 2003-03-28 | Weitz Jeffrey I Ancaster | Clot associated coagulation factors inhibiting heparin compositions |
| US7259152B2 (en) | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| JP2004507562A (ja) * | 2000-09-08 | 2004-03-11 | ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド | 抗血栓性組成物 |
| EP2284535A1 (en) | 2002-03-11 | 2011-02-16 | Momenta Pharmaceuticals, Inc. | Low molecular weight heparins |
| US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
| US8435795B2 (en) * | 2010-01-19 | 2013-05-07 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
| CN103209997B (zh) * | 2010-09-14 | 2016-03-16 | 国立大学法人宫崎大学 | 高纯度肝素及其制备方法 |
| WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
| JP7401882B2 (ja) * | 2016-03-09 | 2023-12-20 | 株式会社糖鎖工学研究所 | 硫酸基を有する糖の製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4987223A (en) * | 1981-12-23 | 1991-01-22 | Choay S.A. | Derivatives of the uronic acid |
| IT1234508B (it) * | 1988-06-10 | 1992-05-19 | Alfa Wassermann Spa | Derivati eparinici e procedimento per la loro preparazione |
| DE3821271A1 (de) * | 1988-06-23 | 1989-12-28 | Solco Basel Ag | Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt |
| IT1234826B (it) * | 1989-01-30 | 1992-05-29 | Alfa Wassermann Spa | Derivati eparinici e procedimento per la loro preparazione |
| US5200523A (en) * | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
-
1992
- 1992-04-17 IT ITBO920140A patent/IT1260136B/it active IP Right Grant
-
1993
- 1993-03-10 AT AT93103847T patent/ATE154615T1/de not_active IP Right Cessation
- 1993-03-10 ES ES93103847T patent/ES2103991T3/es not_active Expired - Lifetime
- 1993-03-10 DK DK93103847.5T patent/DK0565862T3/da active
- 1993-03-10 EP EP93103847A patent/EP0565862B1/en not_active Expired - Lifetime
- 1993-03-10 DE DE69311618T patent/DE69311618T2/de not_active Expired - Fee Related
- 1993-03-12 ZA ZA931799A patent/ZA931799B/xx unknown
- 1993-03-18 NZ NZ247197A patent/NZ247197A/en unknown
- 1993-03-19 IL IL105111A patent/IL105111A/xx not_active IP Right Cessation
- 1993-03-19 TW TW082102015A patent/TW229213B/zh active
- 1993-03-30 NO NO931181A patent/NO306305B1/no not_active IP Right Cessation
- 1993-04-01 CA CA002093148A patent/CA2093148C/en not_active Expired - Fee Related
- 1993-04-13 US US08/046,247 patent/US5430132A/en not_active Expired - Lifetime
- 1993-04-13 AU AU36896/93A patent/AU658499B2/en not_active Ceased
- 1993-04-16 FI FI931740A patent/FI106555B/fi not_active IP Right Cessation
- 1993-04-16 JP JP5089977A patent/JP2702377B2/ja not_active Expired - Fee Related
- 1993-04-17 KR KR1019930006474A patent/KR0171623B1/ko not_active IP Right Cessation
-
1997
- 1997-08-29 GR GR970402225T patent/GR3024582T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL105111A (en) | 1997-03-18 |
| EP0565862A3 (en) | 1993-11-10 |
| FI931740A (fi) | 1993-10-18 |
| KR0171623B1 (ko) | 1999-02-01 |
| JPH0616704A (ja) | 1994-01-25 |
| EP0565862A2 (en) | 1993-10-20 |
| DK0565862T3 (da) | 1997-12-15 |
| NO306305B1 (no) | 1999-10-18 |
| CA2093148C (en) | 1999-01-26 |
| KR930021651A (ko) | 1993-11-22 |
| ATE154615T1 (de) | 1997-07-15 |
| EP0565862B1 (en) | 1997-06-18 |
| AU3689693A (en) | 1993-10-21 |
| CA2093148A1 (en) | 1993-10-18 |
| ITBO920140A0 (it) | 1992-04-17 |
| TW229213B (no) | 1994-09-01 |
| DE69311618D1 (de) | 1997-07-24 |
| DE69311618T2 (de) | 1997-12-11 |
| ES2103991T3 (es) | 1997-10-01 |
| FI106555B (fi) | 2001-02-28 |
| NO931181D0 (no) | 1993-03-30 |
| NO931181L (no) | 1993-10-18 |
| ITBO920140A1 (it) | 1993-10-17 |
| FI931740A0 (fi) | 1993-04-16 |
| IT1260136B (it) | 1996-03-28 |
| GR3024582T3 (en) | 1997-12-31 |
| US5430132A (en) | 1995-07-04 |
| JP2702377B2 (ja) | 1998-01-21 |
| AU658499B2 (en) | 1995-04-13 |
| NZ247197A (en) | 1995-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW239148B (no) | ||
| TW229213B (no) | ||
| DE3871637D1 (en) | Pentasaccharide. | |
| GR3024710T3 (en) | Process for the synthesis of semisynthetic glycosaminoglycans containig alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3. | |
| GR3024416T3 (en) | Process for the synthesis of semisynthetic glycosaminoglycans with heparin or heparan structure modified in position 2 of the alpha-L-iduronic-2-0-sulfate acid. |